Related references
Note: Only part of the references are listed.Home-based gait analysis as an exploratory endpoint during a multicenter phase 1 trial in limb girdle muscular dystrophy type R2 and facioscapulohumeral muscular dystrophy
Teresa Gidaro et al.
MUSCLE & NERVE (2022)
Clinical efficacy of the enzyme replacement therapy in patients with late-onset Pompe disease: a systematic review and a meta-analysis
Berli Sarah et al.
JOURNAL OF NEUROLOGY (2022)
Are there common walking gait characteristics in patients diagnosed with late-onset Pompe disease?
Chelsea Starbuck et al.
HUMAN MOVEMENT SCIENCE (2021)
Spanish Pompe registry: Baseline characteristics of first 49 patients with adult onset of Pompe disease
Jorge Alonso-Perez et al.
MEDICINA CLINICA (2020)
Whole-body magnetic resonance imaging in late-onset Pompe disease: Clinical utility and correlation with functional measures
Aleena A. Khan et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
Quantification of Neuromuscular Fatigue: What Do We Do Wrong and Why?
Nicolas Place et al.
SPORTS MEDICINE (2020)
Follow-up of late-onset Pompe disease patients with muscle magnetic resonance imaging reveals increase in fat replacement in skeletal muscles
Claudia Nunez-Peralta et al.
JOURNAL OF CACHEXIA SARCOPENIA AND MUSCLE (2020)
Late-onset Pompe disease (LOPD) in Belgium: clinical characteristics and outcome measures
P. Vanherpe et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Long-term benefit of enzyme replacement therapy with alglucosidase alfa in adults with Pompe disease: Prospective analysis from the French Pompe Registry
Claudio Semplicini et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2020)
Exercise training alone or in combination with high-protein diet in patients with late onset Pompe disease: results of a cross over study
Annalisa Sechi et al.
ORPHANET JOURNAL OF RARE DISEASES (2020)
Characterization of Gait and Postural Regulation in Late-Onset Pompe Disease
Ilka Schneider et al.
APPLIED SCIENCES-BASEL (2020)
Updated methodological guidance for the conduct of scoping reviews
Micah D. J. Peters et al.
JBI EVIDENCE SYNTHESIS (2020)
Large variation in effects during 10 years of enzyme therapy in adults with Pompe disease
Laurike Harlaar et al.
NEUROLOGY (2019)
Safety, tolerability, pharmacokinetics, pharmacodynamics, and exploratory efficacy of the novel enzyme replacement therapy avalglucosidase alfa (neoGAA) in treatment-naive and alglucosidase alfa-treated patients with late-onset Pompe disease: A phase 1, open-label, multicenter, multinational, ascending dose study
Loren D. M. Pena et al.
NEUROMUSCULAR DISORDERS (2019)
Correction of Biochemical Abnormalities and Improved Muscle Function in a Phase I/II Clinical Trial of Clenbuterol in Pompe Disease
Dwight D. Koeberl et al.
MOLECULAR THERAPY (2018)
Quantification of intramuscular fat in patients with late-onset Pompe disease by conventional magnetic resonance imaging for the long-term follow-up of enzyme replacement therapy
Andre Lollert et al.
PLOS ONE (2018)
Association of Muscle Strength and Walking Performance in Adult Patients With Pompe Disease
Marein M. Favejee et al.
PHYSICAL THERAPY (2018)
Quantitative muscle MRI to follow up late onset Pompe patients: a prospective study
Sebastian Figueroa-Bonaparte et al.
SCIENTIFIC REPORTS (2018)
Survival and long-term outcomes in late-onset Pompe disease following alglucosidase alfa treatment: a systematic review and meta-analysis
Benedikt Schoser et al.
JOURNAL OF NEUROLOGY (2017)
The emerging phenotype of late-onset Pompe disease: A systematic literature review
Justin Chan et al.
MOLECULAR GENETICS AND METABOLISM (2017)
Rate of force development: physiological and methodological considerations
Nicola A. Maffiuletti et al.
EUROPEAN JOURNAL OF APPLIED PHYSIOLOGY (2016)
Observational clinical study of 22 adult-onset Pompe disease patients undergoing enzyme replacement therapy over 5 years
Karolina M. Stepien et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Prospective exploratory muscle biopsy, imaging, and functional assessment in patients with late-onset Pompe disease treated with alglucosidase alfa: The EMBASSY Study
Ans van der Ploeg et al.
MOLECULAR GENETICS AND METABOLISM (2016)
Quantitative analysis of upright standing in adults with late-onset Pompe disease
Maria Stella Valle et al.
SCIENTIFIC REPORTS (2016)
Muscle MRI Findings in Childhood/Adult Onset Pompe Disease Correlate with Muscle Function
Sebastian Figueroa-Bonaparte et al.
PLOS ONE (2016)
Characterization of gait in late onset Pompe disease
Paul T. McIntosh et al.
MOLECULAR GENETICS AND METABOLISM (2015)
Safety and efficacy of exercise training in adults with Pompe disease: evalution of endurance, muscle strength and core stability before and after a 12 week training program
Linda E. M. van den Berg et al.
ORPHANET JOURNAL OF RARE DISEASES (2015)
Effect of enzyme replacement therapy on isokinetic strength for all major muscle groups in four patients with Pompe disease-a long-term follow-up
Christer Swan Andreassen et al.
MOLECULAR GENETICS AND METABOLISM (2014)
Ankle muscle strength discriminates fallers from non-fallers
Thomas Cattagni et al.
FRONTIERS IN AGING NEUROSCIENCE (2014)
The French Pompe registry. Baseline characteristics of a cohort of 126 patients with adult Pompe disease
P. Laforet et al.
REVUE NEUROLOGIQUE (2013)
36 months observational clinical study of 38 adult Pompe disease patients under alglucosidase alfa enzyme replacement therapy
Caroline Regnery et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2012)
Open-label extension study following the Late-Onset Treatment Study (LOTS) of alglucosidase alfa
Ans T. van der Ploeg et al.
MOLECULAR GENETICS AND METABOLISM (2012)
Consensus treatment recommendations for late-onset Pompe disease
Edward J. Cupler et al.
MUSCLE & NERVE (2012)
New motor outcome function measures in evaluation of Late-Onset Pompe disease before and after enzyme replacement therapy
Corrado Angelini et al.
MUSCLE & NERVE (2012)
Clinical features and predictors for disease natural progression in adults with Pompe disease: a nationwide prospective observational study
Nadine A. M. E. van der Beek et al.
ORPHANET JOURNAL OF RARE DISEASES (2012)
Effect of aerobic and resistance exercise training on late-onset Pompe disease patients receiving enzyme replacement therapy
Gerasimos Terzis et al.
MOLECULAR GENETICS AND METABOLISM (2011)
Fatigue in neuromuscular disorders: focus on Guillain-Barr, syndrome and Pompe disease
J. M. de Vries et al.
CELLULAR AND MOLECULAR LIFE SCIENCES (2010)
The test-retest reliability of centre of pressure measures in bipedal static task conditions - A systematic review of the literature
Alexander Ruhe et al.
GAIT & POSTURE (2010)
Changes in skeletal muscle qualities during enzyme replacement therapy in late-onset type II glycogenosis: temporal and spatial pattern of mass vs. strength response
Sabrina Ravaglia et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Long-term observational, non-randomized study of enzyme replacement therapy in late-onset glycogenosis type II
Bruno Bembi et al.
JOURNAL OF INHERITED METABOLIC DISEASE (2010)
Enzyme replacement therapy with alglucosidase alfa in 44 patients with late-onset glycogen storage disease type 2: 12-month results of an observational clinical trial
S. Strothotte et al.
JOURNAL OF NEUROLOGY (2010)
A Randomized Study of Alglucosidase Alfa in Late-Onset Pompe's Disease.
Ans T. van der Ploeg et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Rate of disease progression during long-term follow-up of patients with late-onset Pompe disease
N. A. M. E. Van der Beek et al.
NEUROMUSCULAR DISORDERS (2009)
BALANCE CONTROL IN PATIENTS WITH DISTAL VERSUS PROXIMAL MUSCLE WEAKNESS
C. G. C. Horlings et al.
NEUROSCIENCE (2009)
Lysosomal storage disease 2 - Pompe's disease
Ans T. van der Ploeg et al.
LANCET (2008)
Clinical features of late-onset Pompe disease: A prospective cohort study
John H. J. Wokke et al.
MUSCLE & NERVE (2008)
Isokinetic muscle testing for weak patients suffering from neuromuscular disorders:: A reliability study
Vincent Tiffreau et al.
NEUROMUSCULAR DISORDERS (2007)
Modification of the natural history of adult-onset acid maltase deficiency by nutrition and exercise therapy
Alfred E. Slonim et al.
MUSCLE & NERVE (2007)
Clinical manifestation and natural course of late-onset Pompe's disease in 54 Dutch patients
MLC Hagemans et al.
BRAIN (2005)
Share Paper
